Skip to main content
. Author manuscript; available in PMC: 2018 Nov 1.
Published in final edited form as: Biol Blood Marrow Transplant. 2017 Jul 25;23(11):1887–1894. doi: 10.1016/j.bbmt.2017.07.014

Table 4.

Characteristics of patients, by receipt of a new mismatched haplotype.

No New Haplotype
(n=20)
New Mismatched Haplotype
(n=20)
P
Age – mean (SD) 38.3 (20.9) 43.1 (19.8) 0.46
Sex – no. (%)
Female 6 (30) 8 (40) 0.74
Male 14 (70) 12 (60)
Disease status– no. (%)
Refractory or Progressive 6 (30) 2 (10) 0.24
Responsive or in Remission 14 (70) 18 (90)
Relapsed < 6 months - no. (%)
Yes 4 (20) 5 (25) >0.99
No 16 (80) 15 (75)
aGVHD Grade 2–4, 1st Transplant - no. (%)
No 14 (70) 13 (65) >0.99
Yes 6 (30) 7 (35)
cGVHD, 1st Transplant - no. (%)
No 16 (80) 15 (75) >0.99
Yes 4 (20) 5 (25)